RA Capital Management’s Obsidian Therapeutics OBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$81.8M Buy
+5,957,103
New +$116M 0.82% 29

Other funds holding OBX

RA Capital Management's OBX Position: Q3 2026 in Review

RA Capital Management opened a new position in Obsidian Therapeutics (OBX) in Q3 2026: 5,957,103 shares worth $81.8M. The stake represents 0.82% of the portfolio and ranks #29 among its holdings.

60 funds tracked by Wall St. Rank hold OBX as of Q3 2026.

  • RA Capital Management held 5,957,103 shares of Obsidian Therapeutics worth $81.8M as of Q3 2026.
  • Obsidian Therapeutics was a new RA Capital Management position in Q3 2026.
  • Obsidian Therapeutics made up 0.82% of RA Capital Management's portfolio in Q3 2026, its #29 holding.
  • 60 funds tracked by Wall St. Rank held Obsidian Therapeutics as of Q3 2026.

Based on RA Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.